Potential 8 month base just starting it's move off the lower support line. Classic 4 point continuation pattern. Stochastics and MACD curling up.
Relief Therapeutics just held a conference call on concluding FDA Phase III trials for severe Covid using the drug Aviptadil (Zyesami). Expect filing for FDA EUA approval within a week and FDA approval in 30 days or less thereafter.
Relief Therapeutics just held a conference call on concluding FDA Phase III trials for severe Covid using the drug Aviptadil (Zyesami). Expect filing for FDA EUA approval within a week and FDA approval in 30 days or less thereafter.
免責聲明
這些資訊和出版物並非旨在提供，也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。